This was further confirmed by the analysis of paraffin fixed GBM patient brain tissues (n = 4), which identified a heterogeneous p65 protein expression pattern in CD68+ myeloid cells (Fig. 6D). This evidence concerns the gene CD68 and glioblastoma.